Thursday, October 16, 2025
Home Health and Wellness Cuban Drug HeberprotP Authorized For Clinical Trial in the US

Cuban Drug HeberprotP Authorized For Clinical Trial in the US

Havana, Cuba – May 2014 – teleSUR – The Cuban drug Heber­prot-p received autho­rization for the devel­opment of a clinical trial in the U.S. . At the end of the year, the Bio­cubafarma Business Group announced on its Facebook page. Biocubafarma ex­plained that Discovery Therapeutics Caribe (DTC), an American company specialized in biotechnology, will be…

This content is for 3 Months, 6 Months, and 12 Months members only.
Join Now
Already a member? Log in here
- Advertisment -

Most Popular

Recent Comments

Government Handling of Crime Poll

Results: 0 Yes / 0 No